|
BioInvent International AB |
|
|
Solvegatan 41
Lund, SE-22370 Sweden
phone:46 (46) 286 85 50
fax:46 (46) 2110806
|
|
| Symbol |
BINV |
| Exchange |
STO |
| Founded |
0 |
| Employees |
|
|
|
| www.bioinvent.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutic antibody drugs for cancer, AIDS, and other diseases. |
|
| Management |
| Svein Mathisen, President and CEO; Cristina Glad, Executive Vice President; Steven Glazer, Senior Vice President, Development; Per-Anders Johansson, Vice President, Quality Assurance and Regulatory Affairs; Martin Wiles, Senior Vice President, Business Development |
| |
|
|
|
|
|
|
|
| Keywords |
| antibodies, biopharmaceuticals, biomanufacturing, hiv, aids, atherosclerosis, osteoarthrites, cancer, antibody, drugs, HIVAIDS |
|
|
|
| Description |
|
BioInvent International AB is dedicated to working with clients in the discovery, development and manufacture of antibody drugs for diseases with unmet medical needs, such as HIV/AIDS, unstable plaque for atherosclerosis, disease modification of osteoarthrtis, and cancer. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
